TRexBio

TRexBio, Inc. is a clinical-stage biotechnology company headquartered at 681 Gateway Blvd in South San Francisco, California, founded in 2018 and seed funded by SV Health Investors, that discovers and develops immunoregulatory biologics based on tissue regulatory T cell (Treg) biology. Its Deep Biology Platform combines human tissue samples, computational biology and immunobiology expertise to map how tissue Tregs behave in disease and to identify and characterize novel targets for inflammatory, autoimmune and other immune-mediated conditions. Disclosed programs include TRB-061, the CD30 agonist TRB-071, TRB-081, and the Lilly-partnered TRB-051, with Phase 1 trials expected to initiate in 2027. The company announced an $84 million Series B in November 2024 and closed a further $50 million financing in January 2026; investors include Eli Lilly and Company, Pfizer Ventures, Johnson & Johnson, SV Health Investors and Polaris Partners. TRexBio publishes no developer program, API documentation, SDK or machine-readable API contract. trex.bio is a WordPress marketing site whose only machine-readable surfaces are the WordPress core REST API, a Yoast-generated llms.txt, and an OAuth-protected WordPress MCP adapter endpoint — CMS infrastructure rather than a product API.

TRexBio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Pharmaceuticals, and Immunology.

TRexBio’s developer surface includes engineering blog and 18 more developer resources.

🌐 Visit website 📡 Source on GitHub

10.6/100 minimal ▬ flat Agent 0/100 human only saas Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0

0 APIs 1 MCP Servers

Company Biotechnology Life Sciences Pharmaceuticals Immunology Drug DiscoveryRegulatory T CellsClinical Stage Computational Biology TherapeuticsSouth San Francisco

Kin Score

Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0

Composite quality — 10.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.3 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/trexbio: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

MCP Servers 1

Model Context Protocol servers that expose these APIs to AI agents.

TRexBio MCP Server

MCP SERVER

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Trexbio Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

MCPServer

MCPServer

LLMsTxt

LLMsTxt

WellKnown

WellKnown

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

Blog

BlogFeeds

Careers

LinkedIn

Investors

Investors

Scroll for all 7

Other 4

Properties that don't map to a standard resource type

Platform

Pipeline

Research

CookiePolicy

Source (apis.yml)

aid: trexbio
name: TRexBio
description: TRexBio, Inc. is a clinical-stage biotechnology company headquartered at 681 Gateway Blvd in South San Francisco,
  California, founded in 2018 and seed funded by SV Health Investors, that discovers and develops immunoregulatory biologics
  based on tissue regulatory T cell (Treg) biology. Its Deep Biology Platform combines human tissue samples, computational
  biology and immunobiology expertise to map how tissue Tregs behave in disease and to identify and characterize novel targets
  for inflammatory, autoimmune and other immune-mediated conditions. Disclosed programs include TRB-061, the CD30 agonist
  TRB-071, TRB-081, and the Lilly-partnered TRB-051, with Phase 1 trials expected to initiate in 2027. The company announced
  an $84 million Series B in November 2024 and closed a further $50 million financing in January 2026; investors include Eli
  Lilly and Company, Pfizer Ventures, Johnson & Johnson, SV Health Investors and Polaris Partners. TRexBio publishes no developer
  program, API documentation, SDK or machine-readable API contract. trex.bio is a WordPress marketing site whose only machine-readable
  surfaces are the WordPress core REST API, a Yoast-generated llms.txt, and an OAuth-protected WordPress MCP adapter endpoint
  — CMS infrastructure rather than a product API.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://trex.bio/wp-content/uploads/2025/10/cropped-Group-3.png
url: https://raw.githubusercontent.com/api-evangelist/trexbio/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Life Sciences
- Pharmaceuticals
- Immunology
- Drug Discovery
- Regulatory T Cells
- Clinical Stage
- Computational Biology
- Therapeutics
- South San Francisco
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: MCPServer
  url: mcp/trexbio-mcp.yml
- type: Website
  url: https://trex.bio/
- type: About
  url: https://trex.bio/about-trex-bio/
- type: Platform
  url: https://trex.bio/deep-biology-platform/
- type: Pipeline
  url: https://trex.bio/pipeline/
- type: Blog
  url: https://trex.bio/news/
- type: BlogFeeds
  url: https://trex.bio/feed/
- type: Research
  url: https://trex.bio/news/
- type: Careers
  url: https://trex.bio/careers/
- type: Contact
  url: https://trex.bio/contact-us/
- type: TermsOfService
  url: https://trex.bio/terms-of-use/
- type: PrivacyPolicy
  url: https://trex.bio/privacy-policy/
- type: CookiePolicy
  url: https://trex.bio/cookie-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/trexbio-inc/
- type: GitHubOrganization
  url: https://github.com/trexbio
- type: Investors
  url: https://forgeglobal.com/trexbio_stock/
- type: LLMsTxt
  url: llms/trexbio-llms.txt
- type: WellKnown
  url: well-known/trexbio-well-known.yml
- type: DomainSecurity
  url: security/trexbio-domain-security.yml
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: 'TRexBio is a clinical-stage Treg biologics company with no developer program at all — trex.bio is a WordPress/WP
    Engine marketing site, and the only machine-readable things on it are stock CMS plumbing: the WordPress core REST API
    at /wp-json/ (342 routes, all of them WordPress and plugin routes), a Yoast-SEO-generated /llms.txt listing news posts
    and careers pages, and an undocumented WordPress MCP adapter at /wp-json/mcp/mcp-oauth-server that returns 401 mcp_unauthorized
    to anonymous tools/list — there is no product API, no /openapi.json, no docs host, and github.com/trexbio has zero public
    repositories.'
  evidence:
  - url: https://trex.bio/openapi.json
    status: 404
  - url: https://trex.bio/graphql
    status: 404
  - url: https://trex.bio/.well-known/agent-card.json
    status: 404
  - url: https://trex.bio/wp-json/mcp/mcp-oauth-server
    status: 401
  - url: https://trex.bio/llms.txt
    status: 200
  - url: https://api.github.com/orgs/trexbio/repos
    status: 200
  checked: '2026-08-05'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/trexbio"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/trexbio/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/trexbio/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.